What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Cell biology, Internal medicine, Endocrinology, Cancer research and Carcinogenesis.
His Cell biology research is multidisciplinary, incorporating perspectives in Embryonic stem cell and DNA damage, Genome instability.
While the research belongs to areas of DNA damage, he spends his time largely on the problem of Suppressor, intersecting his research to questions surrounding Mitotic spindle checkpoint.
His Hormone, Insulin receptor and Cholesterol 7 alpha-hydroxylase study, which is part of a larger body of work in Endocrinology, is frequently linked to Leptin, bridging the gap between disciplines.
His Cancer research research includes elements of Cancer stem cell and Pancreas.
Chu-Xia Deng focuses mostly in the field of Carcinogenesis, narrowing it down to matters related to Germline mutation and, in some cases, Mutant.
His most cited work include:
- Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control (1880 citations)
- Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control (1880 citations)
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks (1131 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cancer research, Cell biology, Internal medicine, Endocrinology and Molecular biology.
His work carried out in the field of Cancer research brings together such families of science as Cancer, Carcinogenesis, Tumor suppressor gene, Cell cycle and Breast cancer.
He focuses mostly in the field of Cell biology, narrowing it down to topics relating to Embryonic stem cell and, in certain cases, Stem cell.
His research integrates issues of Oncology and Endochondral ossification in his study of Internal medicine.
The study incorporates disciplines such as Receptor, Muscarinic acetylcholine receptor, Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M4 and Fibroblast growth factor receptor 3 in addition to Endocrinology.
His Molecular biology research is multidisciplinary, relying on both DNA damage, Mutant, Gene, DNA repair and Genetically modified mouse.
He most often published in these fields:
- Cancer research (35.06%)
- Cell biology (35.48%)
- Internal medicine (26.56%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (35.06%)
- Cell biology (35.48%)
- Cancer (12.24%)
In recent papers he was focusing on the following fields of study:
Chu-Xia Deng mainly investigates Cancer research, Cell biology, Cancer, Internal medicine and Breast cancer.
His work deals with themes such as Cisplatin, Cancer cell, Carcinogenesis, Gene and Stem cell, which intersect with Cancer research.
His Cell biology research incorporates themes from Embryonic stem cell, DNA damage, TFEB and Zebrafish.
His studies deal with areas such as Mutation and Immunology as well as Cancer.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology.
His studies in Breast cancer integrate themes in fields like Apoptosis and Ovarian cancer.
Between 2015 and 2021, his most popular works were:
- The role of TGF-β/SMAD4 signaling in cancer. (135 citations)
- Emerging roles of SIRT1 in fatty liver diseases. (100 citations)
- Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers. (73 citations)
In his most recent research, the most cited papers focused on:
Chu-Xia Deng focuses on Cancer research, Cancer, Internal medicine, Cell biology and Gene.
His biological study spans a wide range of topics, including Cancer cell, Cancer stem cell, Breast cancer and Cisplatin.
His work in the fields of Cancer, such as Carcinogenesis and Triple-negative breast cancer, intersects with other areas such as Prognostics and Membrane vesicle.
His study looks at the intersection of Internal medicine and topics like Endocrinology with Histone H4.
Chu-Xia Deng does research in Cell biology, focusing on Phosphorylation specifically.
The study incorporates disciplines such as Transforming growth factor beta and Signal transduction in addition to Gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
